Skip to content

Category Archives: Development Stage Medical Device Company

Video > Endovascular Repair for Abdominal Aortic Aneurysm AAA > Harper University Hospital > Patients receives endoluminal repair > Endovascular stent-graft require periodic follow-up > Check for migration and endoleaks

Tuesday, February 19, 2008

IIP > View here…

> Performed by Ali Kafi, M.D., F.A.C.S., F.A.C.C., F.A.C.P.hief of Cardiovascular Thoracic Surgery, Harper University Hospital
Clinical Associate Professor of Surgery (WSU)
PRIMARY HOSPITAL: Harper University Hospital
SPECIALTY: Cardiothoracic surgery, minimally invasive cardiac surgery, robotic surgery, valvular surgery, endovascular grafting, balloon angioplasty & stenting, treatment of Atrial Fibrillation
BOARD CERTIFICATION: American Board of Surgery, American Board […]

Filed in Development Stage Medical Device Company, GORE EXCLUDER AAA Endoprosthesis, Life Line Screening, Entrepreneurs and investors, Medical Device Company, Aorfix Dacron stent-graft, Surgical revision, Boston Scientific Corp.'s Guidant unit, Medtronic, Benefit from screening, Stent grafts have a tendency to migrate, Fixation of stent grafts, EndoRefix, Endoleaks, Keep the graft in place, Vascular surgery business, Boston Scientific, Ethics, Lombard Medical, Stent graft migration following endovascular aneurysm r, Johnson & Johnson’s Ethicon division, Men in England are to be offered AAA screening, European collaborators on stent graft techniques for ab, B Braun Melsungen AG, Medical device business incubators, Glidewire Hydrophilic Coated Guidewire, Terumo Corporation, AcroMIS LLC, Complication of stent-graft repair, Paraplegia secondary to spinal cord ischaemia, Ethicon Endo-Surgery, Aneurysm rupture, Type I endoleaks, NoScarSurgeons.com, EUROSTAR, Endovascular techniques prone to similar complications, Henry Ford Hospital Detroit, Stent graft fixation product, Lombard Medical Technologies, Watchful waiting, Treatment of aneurysms, Albert Einstein, Open aneurysm repair, Surgical aneurysm repair, Endoaneurysmorrhaphy, Elective surgical treatment of AAA, Minimally invasive surgery techniques, Sudden severe back or abdominal pain, Risk of developing AAA, Rupture of an abdominal aortic aneurysm, MIS Abdominal Aortic Aneurysm Repair AAA, Minimally Invasive Surgery MIS, Ultrasound screening, Abdominal aortic aneurysm AAA, Silent killer, Endovascular stent graft, Totally laparoscopic AAA replacement, Larger aneurysms can leak or rupture, Welcome to Medicare physical, Free screening for AAA, Ascending aortic aneurysm, Screen the aorta, Scanning and visualizing the aorta, Stent Stapler, Stapling may replace stitching, Swanstrom, Simple $50 ultrasound scan, Stent-graft technology under serious scrutiny, Long-term graft performance, Need for reintervention, Endovascular stenting, Start-up companies, AAA stent-graft device, Subsidiary of a major stent-graft company, Warning letter, Medical Device Development | Comments (0)

Neurotechnology is the new frontier > Changing the way medicine is practiced > Cyberkinetics’ Andara OFS System > Treatment of acute spinal cord injury > Cyberonics’ VNS Therapy > Pulsed signals delivered to the brain via the vagus nerve > Dramatic quality-of-life changes for patients > Micrus Endovascular in San Jose CA > ACT MicroCoil Delivery System > Treat hemorrhagic stroke victims > Center for Integration of Medicine and Innovative Technology CIMIT > Clinicians at Harvard teaching hospitals and Boston Medical Center > Medtronic > St. Jude Medical > Neurotechnology Industry Organization NIO San Francisco > National Neurotechnology Initiative > Accelerating translational neurotech innovation > Improving the timeliness of the FDA review

Friday, February 8, 2008

What are the treatment options for stroke or traumatic spinal cord injury? Can treatments influence the deteriorating effects of diseases such as Alzheimer’s or even severe depression? Will advances in neurotechnology bring the medical device industry new revenue and profit potential while helping to improve patients’ quality of life?

IIP > Read on here…
As neuromodulation grows […]

Filed in Treatment of acute spinal cord injury, Pulsed signals delivered to brain, Via the vagus nerve, Clinicians at Harvard teaching hospitals and Boston uni, Treat hemorrhagic stroke victims, ACT MicroCoil Delivery System, Cyberonics’ VNS Therapy, Cyberkinetics’ Andara OFS system, Micrus Endovascular, Center for Integration of Medicine and Innovative Techn, Steven Schachter, Daniel Moore, CCF Innovations Cleveland Clinic’s commercialization , Christopher Coburn, Andara OFS System, Since 1997 42,000 patients received VNS Therapy for epi, Therapeutic utility of VNS Therapy for bulimia > Obe, CIMIT, CIMIT NeuroTechnology Program, Bridges between technology partners MIT > Draper Lab, Markets include pain management > stroke movement re, Device treatments will replace current option w/ drugs, Minimally invasive instruments and surgical robotics, Combining robotic technology and computerized movement, Electromechanical catheter manipulator cntrolled with c, Catheter-based Endoluminal Surgery System, Cyberonics, Development Stage Medical Device Company, Incision-less solutions, Harvard Medical School, Medtronic, Man Machine Systems, Neurotechnology > A new frontier, Help aging populations live longer and with quality of , Leerink Swann full-service investment banking service B, Neurotechnology is changing the way medicine is practic, Large unmet medical market opportunity, Brain-related illnesses, Cardiology markets maturing > decline, Neurotechnology Industry Organization San Francisco CA, Zack Lynch, No Scar Surgery | Comments (0)

ConforMIS receives EU approval for knee surgery technology > iUni Implant resurface portions on the knee due to arthritic damage > iJig cutting and placement tool is designed to limit the number of instruments needed > European market clearance for a knee implant and related surgical instrument

Wednesday, January 23, 2008

Is the fundamental challenge in a complex 3-D structure like the knee that surgeons must cut bone to fit the patient to the implant? Does ConforMIS use data from MRIs or CT scans taken before surgery to generate a 3-D model of a patient’s knee and design an implant to conform exactly to the area […]

Filed in Design implant to conform exactly, Surgeons cut bone to fit the patient, Data from MRIs or CT scans taken before surgery, No implant inventory for the company, Knee implant and related surgical instrument, Shaped for each patient, iJig cutting and placement tool, iUni, Minimally invasive knee replacement, Spin-off of Imaging Therapeutics, Minimally invasive approach, Minimally invasive surgery techniques, Less-invasive, Initial Public Offering IPO, Development Stage Medical Device Company, ConforMIS, Medical Device Company, Entrepreneurs and investors, Minimally Invasive Surgery MIS | Comments (0)

AID Appendoectomy™ Inverter Device > Minos Medical Inc gains CE mark > Megachannel™ mounted on the standard colonoscope > New natural orifice surgery appendectomy products > Minos Medical’s colonic access device guided through the caecum > Keyhole surgery approaches the appendix via the colon > For patients with limited inflammation and little adhesions

Monday, January 14, 2008

Will the first generation products be refined in further laboratory work and under laparoscopic control as part of a clinical trial? Is the Megachannel™ device suitable for a series of products for both endoluminal and transluminal procedures? Will it be possible to get a better image of the appendix prior to attempting the removal […]

Filed in NOTES and hybrid NOTES procedures, Development Stage Medical Device Company, Hybrid and endoluminal treatment options, flexibility of the endoscope tip, Clinical and physiologic patterns, Minos Medical Inc, Minos Medical's colonic access device, Christoph Gasche, Natural orifice surgery appendectomy, AID Appendoectomy™ Inverter Device, Endoscopy Endoscopic, Hybrid procedures combining endoscopy and laparoscopy, NOTES, Hybrid, NOTES & NEWS, Endoluminal Endolumenal Hollow Vessel, Flexible endoscope, Initial applications of NOTES, Flexible scope, Flexible endoscopes that have working channels, NOTES techniques, Hybrid Endoluminal Endolumenal Laparoscopic MIS | Comments (0)

Cleveland Clinic Surgeon Performs First Single-Port Laparoscopic Radical Prostatectomy and Single-Port Laparoscopic Radical Cystectomy > Jihad H Kaouk > Single-Port Laparoscopic SPL > Uni-X Single Port Laparoscopic System > Gregory Piskun > Pnavel Systems

Wednesday, December 12, 2007

Will single port surgery where all instruments used are passed through the single port without the use of any 2 mm or 3 mm instruments for retraction or assistance replace conventional laparoscopy? Will the new SPL technique improve patient’s outcomes and saving cost? Are multiple abdominal wall incisions and laparoscopic ports a technique of the […]

Filed in Single-Port Laparoscopic Radical Cystectomy, Jihad H Kaouk, Single-Port Laparoscopic Radical Prostatectomy, One Port Umbilicus Surgeries OPUS, No visible skin scar, Single Port Laparoscopy, Single Port Laparoscopic SPL, Uni-X Single Port Laparoscopic System, Single Port Retroperitoneal Kidney Surgery, single port laparoscopic pediatric surgery, Single small umbilical incision, Pnavel Systems, Gregory Piskun, Scarless single port procedures SPA, Single Port Access SPA, Laparoscopic or open surgical procedures, Laparoscopic tools, No-scar abdominal surgery, No Scar Surgery, Laparoscopy Laparoscopic, Minimally Invasive Surgery MIS, Minimally invasive approach, Endoscopy Endoscopic, Development Stage Medical Device Company, single Port, Single incision, Laparoscopic technique, Laparoscopy, Ideas For Surgery News | Comments (0)

EnteroMedics Inc. Announces Initial Public Offering IPO > Development Stage Medical Device Company > Neuroblocking Technology > VBLOC™ Vagal Blocking Therapy With Maestro System For Treatment Of Obesity

Saturday, November 17, 2007

Will neuroblocking technology and VBLOC™ vagal blocking therapy be successful in treating obesity? Why was the planned initial public offering at 5 million shares for an estimated price of $14 to $16 reduced to $8 per share? Do investors appreciate EnteroMedics Inc, a development stage medical device company as a viable option to treat obesity?

[…]

Filed in Neuroblocking Technology, Development Stage Medical Device Company, Vagal Blocking Therapy, Maestro System, Obesity, Treatment Of Obesity, Initial Public Offering IPO, EnteroMedics Inc, GERD, FDA regulators, EndoRefix, Diabetes, Body mass index, Disclosing new technology and innovations | Comments (0)